Agilent (Santa Clara, California, USA) will collaborate with the Samsung Medical Centre, one of South Korea's leading medical institutes, on medicine and genetics research projects.
Agilent (Santa Clara, California, USA) will collaborate with the Samsung Medical Centre, one of South Korea's leading medical institutes, on medicine and genetics research projects.
The department of laboratory medicine and genetics research, which is part of the centre, will use Agilent's bio-analytical instruments to analyse clinical samples and develop novel clinical assays.
Professor Sung-Hwa Hong, executive vice president, research and development, Samsung Medical Centre, said: “Based on our memoradum of understanding, projects such as the discovery and validation of protein biomarkers for applications in clinical trials, the development of methodology for applications involving hormones and vitamins, and assay development for a tumour marker for certain cancers and diseases will be undertaken at Samsung Medical Centre in cooperation with Agilent.”
Rod Minett, general manager of Agilent's life sciences business in South Korea and the South Asia Pacific commented: “For the detailed and rigorous tests required for these research projects, Agilent will provide our bio-analytical instruments, on-site and remote application and technical support, as well as our research experts to work closely with professor Hong's team. We look forward to close collaboration with Samsung Medical Centre to accelerate the advancement of science and medical developments, and ultimately to improve the quality of life for mankind.”
For more information please visit ref="http://www.agilent.com">www.agilent.com
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.